Hidenori Matsuo - Concepedia

Author

Hidenori Matsuo

Tehran University of Medical Sciences ORCID

Also Known As

H Matsuo, H. Matsuo, Hidenori MATSUO, Hidenori Matsuo, Hidenori Matsuo (705865), Salvatore Cuzzocrea, Zahra Aghazadeh

Publications

461

Citations

H-Index

Concepts

All Affiliations

Tehran University of Medical Sciences Nagasaki Kawatana Medical Center University of Messina Massey University Shahid Sadoughi University of Medical Sciences and Health Services

About

Hidenori Matsuo is an author at Tehran University of Medical Sciences specializing in medicine, pharmacology, and rheumatology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	171
2	Natural Sciences	2	2	167
3	Engineering	1	1	144
4	Social Sciences	1	1	26
5	Biostatistics	1	1	144

Hidenori Matsuo

Publications

433

Citations

H-Index

Page 1

	Year	Citations
Segmenting Lung Fields in Serial Chest Radiographs Using Both Population-Based and Patient-Specific Shape Statistics Yonghong Shi, Feihu Qi, Zhong Xue, IEEE Transactions on Medical Imaging Computed TomographyEngineeringStatistical Shape AnalysisBiometricsShape Analysis	2008	144
Novel Immunosuppressive Therapy by M2000 in Experimental Multiple Sclerosis Abbas Mirshafiey, Hidenori Matsuo, Shunya Nakane, Immunopharmacology and Immunotoxicology	2005	61
Evaluation of the efficacy and safety of β-d-mannuronic acid in patients with ankylosing spondylitis: A 12-week randomized, placebo-controlled, phase I/II clinical trial Mohammad Javad Fattahi, Ahmadreza Jamshidi, Mahdi Mahmoudi, International Immunopharmacology RheumatologySpondyloarthritisβ-D-mannuronic Acid12-Week RandomizedInflammatory Rheumatic Disease	2017	30
Resistance to ischemic conduction block of the peripheral nerve in hyperglycemic rats: An electrophysiological study Susumu Shirabe, Ikuo Kinoshita, Hidenori Matsuo, Muscle & Nerve Peripheral Nerve InjuryAnesthetic MechanismPeripheral NerveExperimental PharmacologyPeripheral Nervous System	1988	26
Administration of aminoglycosides to hemodialysis patients immediately before dialysis: a new dosing modality Hidenori Matsuo, Junichi Hayashi, Koji Ono, Antimicrobial Agents and Chemotherapy Pharmaceutical ScienceHd SessionDialysisDialysis TherapyAntimicrobial Chemotherapy	1997	26
Introduction of β- d -mannuronic acid (M2000) as a novel NSAID with immunosuppressive property based on COX-1/COX-2 activity and gene expression Abbas Mirshafiey, Mahsa Taeb, Seyed Shahabeddin Mortazavi‐Jahromi, Pharmacological Reports InflammationMedicinal ChemistryAnti-inflammatoryCox-1/cox-2 ActivityMedicine	2017	23
Oral administration effects of β-d-mannuronic acid (M2000) on Th17 and regulatory T cells in patients with ankylosing spondylitis Mohammad Javad Fattahi, Hossein Ahmadi, Fahimeh Jafarnezhad‐Ansariha, Biomedicine & Pharmacotherapy InflammationRheumatologyAutoimmune DiseaseSpondyloarthritisT-regulatory Cell	2018	20
Engineered hepatitis B virus surface antigen L protein particles for in vivo active targeting of splenic dendritic cells Shun’ichi Kuroda, Hidenori Matsuo, Nobuo Yoshimoto, International Journal of Nanomedicine	2012	17
A phase I/II randomized, controlled, clinical trial for assessment of the efficacy and safety of β-d-mannuronic acid in rheumatoid arthritis patients Hossein Ahmadi, Ahmadreza Jamshidi, Farhad Gharibdoost, Inflammopharmacology Rheumatoid DisorderRheumatologyAnti-inflammatoryAutoimmune DiseaseRheumatic Diseases	2018	17
International multicenter randomized, placebo-controlled phase III clinical trial of β-d-mannuronic acid in rheumatoid arthritis patients Zahra Rezaieyazdi, Abid Farooqi, H Soleymani Salehabadi, Inflammopharmacology Rheumatoid DisorderRheumatologyAutoimmune DiseaseMedicineRheumatic Diseases	2019	17

Page 1